Ceryvyn Therapeutics Limited Stock
Stocks
OPT
AU000000OPT2
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0130 AUD | -7.14% |
|
-7.14% | -97.83% |
| Market Cap | 17.78M 12.29M 10.78M 9.95M 9.2M 17.43M 1.18B 120M 46.5M 576M 46.16M 45.15M 2B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | -11.42M -7.89M -6.92M -6.39M -5.9M -11.19M -756M -76.82M -29.85M -370M -29.63M -28.98M -1.28B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 0.71x |
| Free-Float |
74.06% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -7.14% | ||
| 1 week | -7.14% | ||
| Current month | -13.33% | ||
| 1 month | -13.33% | ||
| 3 months | -97.83% | ||
| 6 months | -97.83% | ||
| Current year | -97.83% |
| 1 week | 0.01 |  | 0.02 |
| 1 month | 0.01 | | 0.02 |
| Current year | 0.01 | | 0.02 |
| 1 year | 0.01 | | 0.02 |
| 3 years | 0.01 | | 1.16 |
| 5 years | 0.01 | | 1.48 |
| 10 years | 0.01 | | 4.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeremy Levin
CEO | Chief Executive Officer | 72 | 2025-08-31 |
Hamish George
DFI | Director of Finance/CFO | - | 2025-10-26 |
John Han
CTO | Chief Tech/Sci/R&D Officer | - | 2024-04-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Lawrence Gozlan
BRD | Director/Board Member | 47 | 2020-07-23 |
Jeremy Levin
CHM | Chairman | 72 | 2020-10-04 |
Kathy Connell
BRD | Director/Board Member | 59 | 2024-11-14 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-22 | Buy | Chief Executive Officer | 13,390,000 | 1.0875% | ||
| 06-18 | Free | Chief Executive Officer | 48,000,000 | 3.8984% | ||
| 06-16 | Sell | Director | -1,877,357 | 0.1525% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.14% | -7.14% | -97.83% | -97.72% | 13.28M | |
| -1.53% | +0.78% | +72.33% | +129.70% | 57.72B | |
| -2.45% | -7.83% | +63.92% | +83.15% | 52.65B | |
| +3.27% | +8.91% | +21.21% | +486.76% | 24.46B | |
| -0.81% | -0.42% | -16.24% | -12.47% | 23.84B | |
| +4.71% | +4.18% | +44.25% | -1.68% | 19.28B | |
| -0.24% | +5.11% | +38.76% | -26.41% | 17.8B | |
| +2.34% | +12.50% | +224.02% | +380.99% | 17.29B | |
| -1.04% | +1.33% | +35.45% | - | 15.28B | |
| -1.70% | +3.98% | +28.96% | +190.57% | 14.35B | |
| Average | -0.47% | +4.29% | +41.48% | +125.87% | 24.27B | |
| Weighted average by Cap. | -0.29% | +3.12% | +57.87% | +141.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 1.1M 760K 667K 616K 569K 1.08M 72.81M 7.4M 2.88M 35.63M 2.86M 2.79M 124M |
| Net income | 337M 233M 204M 189M 174M 330M 22.3B 2.27B 881M 10.91B 875M 855M 37.88B | -12.6M -8.71M -7.64M -7.05M -6.52M -12.35M -834M -84.78M -32.94M -408M -32.71M -31.99M -1.42B |
| Net Debt | -29.2M -20.18M -17.7M -16.34M -15.1M -28.63M -1.93B -196M -76.34M -946M -75.8M -74.14M -3.28B | -17M -11.75M -10.31M -9.52M -8.79M -16.67M -1.13B -114M -44.45M -551M -44.13M -43.16M -1.91B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-08 | A$0.0130 | -7.14% | 7,777,329 |
| 26-07-07 | A$0.0140 | -6.67% | 4,723,387 |
| 26-07-06 | A$0.0150 | +7.14% | 9,873,809 |
| 26-07-03 | A$0.0140 | -6.67% | 3,708,050 |
| 26-07-02 | A$0.0150 | +7.14% | 19,796,064 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OPT Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
